{
    "clinical_study": {
        "@rank": "114213", 
        "acronym": "Thyroid cancer", 
        "biospec_descr": {
            "textblock": "Whole blood for UCP2 mRNA"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "This study objective is to evaluate the change in mitochondrial uncoupling protein 2 (UCP2)\n      mRNA expression as function of thyroid activity (TSH, T3 and Free T4)."
        }, 
        "brief_title": "Changes in Metabolic Status in Patients With Total Thyroidectomy", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Thyroid Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Thyroid Neoplasms", 
                "Thyroid Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Blood will be drown before thyroidectomy, 2 weeks after the operation and 3-4 month after\n      the operation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who were diagnosed with thyroid carcinoma and are going to have total\n             thyroidectomy.\n\n          -  Patients with unbalanced thyroid hormones.\n\n          -  Aged 18-65 years at the time of screening.\n\n          -  Provision of written informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients with Diabetes.\n\n          -  Patients with any other chronic inflammatory diseases.\n\n          -  Steroid treatment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who were diagnosed with thyroid carcinoma and are going throgh total\n        thyroidectomy and recive a thyroid replacement therapy."
            }
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01781767", 
            "org_study_id": "TASMC-12-NV-376-CTIL"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "UCP2", 
            "Thyroid function", 
            "Thyroid carcinoma"
        ], 
        "lastchanged_date": "January 30, 2013", 
        "location": {
            "contact": {
                "email": "vaisman@tasmc.health.gov.il", 
                "last_name": "Nachum Vaisman, M.D.", 
                "phone": "972-3-6974807"
            }, 
            "facility": {
                "address": {
                    "city": "Tel Aviv", 
                    "country": "Israel", 
                    "zip": "64239"
                }, 
                "name": "Tel Aviv Sourasky Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "vaisman@tasmc.health.gov.il", 
            "last_name": "Nachum Vaisman, M.D.", 
            "phone": "972-3-6974807"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The difference between the result at two weeks and four months compare to base line.", 
            "measure": "Changes in UCP2 mRNA concentrations.", 
            "safety_issue": "No", 
            "time_frame": "Base line (before opporation), 2 weeks after opporation and for after opporation."
        }, 
        "reference": [
            {
                "PMID": "11427693", 
                "citation": "Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001 Jul;81(3):1097-142. Review."
            }, 
            {
                "PMID": "203955", 
                "citation": "Schwartz HL, Oppenheimer JH. Physiologic and biochemical actions of thyroid hormone. Pharmacol Ther B. 1978;3(3):349-76. Review."
            }, 
            {
                "PMID": "16098826", 
                "citation": "Brand MD, Esteves TC. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab. 2005 Aug;2(2):85-93. Review."
            }, 
            {
                "PMID": "6320232", 
                "citation": "Nicholls DG, Locke RM. Thermogenic mechanisms in brown fat. Physiol Rev. 1984 Jan;64(1):1-64. Review."
            }, 
            {
                "PMID": "20427509", 
                "citation": "Gjedde S, Gormsen LC, Riis AL, J\u00f8rgensen JO, Rungby J, M\u00f8ller N, Weeke J, Pedersen SB. Reduced expression of uncoupling protein 2 in adipose tissue in patients with hypothyroidism. J Clin Endocrinol Metab. 2010 Jul;95(7):3537-41. doi: 10.1210/jc.2009-0907. Epub 2010 Apr 28."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01781767"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "Approximately 4 months"
            }, 
            {
                "measure": "Resting energy expenditure", 
                "safety_issue": "No", 
                "time_frame": "Approximatly 4 months"
            }
        ], 
        "source": "Tel-Aviv Sourasky Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tel-Aviv Sourasky Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2013"
    }
}